During the past decade, Chi Mei Medical Center conducted 101 clinical trials. In the 10-year time frame, 101 clinical trials started and 27 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 59 clinical trials started and 21 clinical trials were completed. i.e. 35.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chi Mei Medical Center" #1 sponsor was "Eli Lilly and Company" with 16 trials, followed by "Hoffmann-La Roche" with 10 trials sponsored, "BeiGene" with 6 trials sponsored, "Boehringer Ingelheim" with 5 trials sponsored and "Janssen Research & Development, LLC" with 5 trials sponsored. Other sponsors include 79 different institutions and companies that sponsored additional 68 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chi Mei Medical Center" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Chi Mei Medical Hospital" with 2 trials as a collaborator and "Galapagos NV" with 2 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Chi Mei Medical Center" are "Hepatocellular Carcinoma" (5 trials), "Type 2 Diabetes Mellitus" (5 trials), "Atrial Fibrillation" (4 trials), "Gastric Cancer" (3 trials) and "Lung Cancer" (3 trials). Many other conditions were trialed in "Chi Mei Medical Center" in a lesser frequency.

Most popular intervention types in "Chi Mei Medical Center" are "Drug" (110 trials), "Other" (8 trials), "Device" (4 trials), "Biological" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Paclitaxel" (7 trials), "Atezolizumab" (6 trials), "Carboplatin" (6 trials) and "Cisplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Chi Mei Medical Center" are 117 trials for "All" genders, 5 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Chi Mei Medical Center". undefined are not yet recruiting, 29 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Chi Mei Medical Center, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Chi Mei Medical Center, 12 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 7 trials that are defined as “Not Applicable".

Chi Mei Medical Center has several departments that took part in Clinical trials: "Chi-Mei Medical Centre; Hematology & Oncology" - 9 trials, "Department of Intensive Care Medicine; Chi Mei Medical Center" - 4 trials